HCB enhances TGF-β1 expression and activation levels in breast cancer cells.
HCB activates TGF-β1 pathways: Smad3, JNK and p38.
The HCB- induced migration and invasion involves TGF-β1 signaling pathways.
HCB modulates AhR levels and activation.
HCB enhances TGF-β1 mRNA expression in an AhR-dependent manner.